Gary Richmond
- Infectious Diseases top 2%
- Virology top 1%
- Emergency Medicine top 2%
- Epidemiology
- Molecular Biology
- Co-authors
- Jeffrey FesselEdwin DeJesusDonald P. KotlerChristian MarsolaisDaniel BergerShannon SchraderPrincy KumarStanley T. Lewis
- Topics
- HIV/AIDS drug development and treatment (19 papers)HIV Research and Treatment (16 papers)HIV/AIDS Research and Interventions (7 papers)
- Partner nations
- United StatesUnited KingdomCanada
In The Last Decade
Gary Richmond
26 papers receiving 1.0k citations
Hit Papers
Peers
Comparison fields: 5 of 75
- Infectious Diseases 746
- Virology 720
- Emergency Medicine 254
- Epidemiology 213
- Molecular Biology 120
Countries citing papers authored by Gary Richmond
This map shows the geographic impact of Gary Richmond's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gary Richmond with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gary Richmond more than expected).
Fields of papers citing papers by Gary Richmond
This network shows the impact of papers produced by Gary Richmond. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gary Richmond. The network helps show where Gary Richmond may publish in the future.
Co-authorship network of co-authors of Gary Richmond
This figure shows the co-authorship network connecting the top 25 collaborators of Gary Richmond. A scholar is included among the top collaborators of Gary Richmond based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gary Richmond. Gary Richmond is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 4 | |
| 2 | 18 | |
| 3 | 117 | |
| 4 | 1 | |
| 5 | 61 | |
| 6 | 21 | |
| 7 | 15 | |
| 8 | 58 | |
| 9 | 45 | |
| 10 | 1 | |
| 11 | 142 | |
| 12 | 9 | |
| 13 | 44 | |
| 14 | 7 | |
| 15 | 78 | |
| 16 | 17 | |
| 17 | 11 | |
| 18 | 61 | |
| 19 | 1 | |
| 20 | 21 |
About Gary Richmond
Gary Richmond is a scholar working on Virology, Infectious Diseases and Hepatology, having authored 26 papers that have together received 1.1k indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (16 papers) and HIV/AIDS Research and Interventions (7 papers). The work is most often cited by research in Virology (720 citations), Infectious Diseases (746 citations) and Emergency Medicine (254 citations). Gary Richmond has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Jeffrey Fessel, Edwin DeJesus, Donald P. Kotler, Christian Marsolais, Daniel Berger, Shannon Schrader, Princy Kumar, Stanley T. Lewis, Steven P. Weinheimer and Brinda Emu. Their work appears in journals such as New England Journal of Medicine, PLoS ONE and The Journal of Infectious Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.